Imricor, founded in 2006, is a pioneering brand in the medical technology industry. They are the first and only company in the world to offer commercially viable and safe iCMR (real-time, MRI-guided cardiac catheterization) products for the ablation catheter market. Imricor's innovative products include the Vision-MR Ablation Catheter and the Advantage-MR EP Recorder/Stimulator, among others.

These products have received CE mark approval, making them a major breakthrough in the field. Led by CEO Steve Wedan, who has over 30 years of experience in the medical device industry, Imricor is dedicated to improving ablation therapy for patients worldwide. The company has achieved significant milestones, such as performing the first diagnostic and ablation procedures, enrolling patients in clinical trials, and receiving CE mark approval for their products.

Imricor's Board of Directors and management team bring a wealth of experience and expertise to the brand. They are committed to advancing medical technology and enhancing patient care. With their presence expanding globally, Imricor continues to revolutionize the field of cardiac catheterization and improve the lives of people around the world